These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32510517)

  • 1. Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry.
    Kisserli A; Audonnet S; Duret V; Tabary T; Cohen JHM; Mahmoudi R
    J Vis Exp; 2020 May; (159):. PubMed ID: 32510517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
    Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
    Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
    Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis?
    Dervillez X; Oudin S; Libyh MT; Tabary T; Reveil B; Philbert F; Bougy F; Pluot M; Cohen JH
    Immunopharmacology; 1997 Dec; 38(1-2):129-40. PubMed ID: 9476124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric measurement of C3b receptors (CR1) on human erythrocytes. II. E-CR1 levels in patients with various diseases and their correlation with B-CR1].
    Itoh Y; Fukunaga Y; Yamamoto M
    Arerugi; 1989 Nov; 38(11):1276-87. PubMed ID: 2534036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
    Cosio FG; Shen XP; Hebert LA
    Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
    Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
    Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for accurate quantification of complement receptor 1 on erythrocytes preserved by fixing or freezing.
    Cockburn IA; Donvito B; Cohen JH; Rowe JA
    J Immunol Methods; 2002 Dec; 271(1-2):59-64. PubMed ID: 12445729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients.
    Teixeira JE; Martinez R; Câmara LM; Barbosa JE
    Mycopathologia; 2001; 152(3):125-33. PubMed ID: 11811640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte complement receptors.
    Birmingham DJ
    Crit Rev Immunol; 1995; 15(2):133-54. PubMed ID: 8573285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The structure and role of CR1 complement receptor in physiology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
    Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
    Complement; 1986; 3(2):88-96. PubMed ID: 2945697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria.
    Tetteh-Quarcoo PB; Schmidt CQ; Tham WH; Hauhart R; Mertens HD; Rowe A; Atkinson JP; Cowman AF; Rowe JA; Barlow PN
    PLoS One; 2012; 7(4):e34820. PubMed ID: 22506052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.
    Oudin S; Libyh MT; Goossens D; Dervillez X; Philbert F; Réveil B; Bougy F; Tabary T; Rouger P; Klatzmann D; Cohen JH
    J Immunol; 2000 Feb; 164(3):1505-13. PubMed ID: 10640768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
    Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
    Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease.
    de Carvalho Lins CE; Pereira Crott LS; Teixeira JE; Barbosa JE
    Lupus; 2004; 13(7):517-21. PubMed ID: 15352423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.